GO
Loading...

Vivus Inc

More

  • Best Performing Weight-Loss Stocks Thursday, 13 May 2010 | 3:45 PM ET
    Nearly two-thirds of American adults are either overweight or obese, and childhood obesity is triple what it was a generation ago. It all adds up to a public health crisis, but for companies that manufacture or sell products, services, diets and foods designed to help people lose weight, it's a $60 billion industry that fattens their stock price. Here are some of the companies associated with the weight-loss industry whose stocks have performed well over the last five years, and are likely to co

    Check out some of the companies associated with the weight-loss industry whose stocks have performed well over the last five years, and are likely to continue.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Lightning Round OT: Owens Illinois, Vivus and More Friday, 16 Apr 2010 | 8:49 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • New Obesity Pills: The Pipeline Getting Fat? Monday, 12 Apr 2010 | 5:50 PM ET

    In the quest to help Americans fight the battle of the bulge 3 new pills may be coming to market by the end of the year. What must you know?

  • The FDA's Big, Fat Advisory Committee Meeting Thursday, 1 Apr 2010 | 2:45 PM ET

    FDA advisory committee votes sometimes end in confusion. First, because the actual vote often gets all convoluted and recounted as some panelists hem and haw about voting thumbs up or thumbs down and try to equivocate their decision. And second, because no matter how many times I've explained it to people here, the votes get misread and miscommunicated as actual approval or rejection of a drug versus a recommendation that the FDA clear or spike a drug.

  • Fat Thursday For Vivus Friday, 26 Mar 2010 | 2:51 PM ET

    Vivus announced this morning that an FDA advisory committee is tentatively scheduled to take a look at its diet drug Qnexa on Thursday, July 15th.

  • Lightning Round OT: Patriot Coal, Boeing and More Thursday, 4 Feb 2010 | 9:12 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • The Skinny On Vivus Wednesday, 20 Jan 2010 | 2:47 PM ET

    The Financial Industry Regulatory Authority, the stock markets' self-policing arm, is looking into trading in Vivus shares around the time it announced its positive late-stage test results on its diet drug, Qnexa.

  • Vivus' Race Against The Clock Monday, 11 Jan 2010 | 2:30 PM ET

    Vivus is getting the JPMorgan Healthcare Conference off to a sexy start. The company announced this morning that its late-stage experimental erectile dysfunction drug apparently gets the job done in 15 minutes.

  • Dow Ekes Out a Gain; VIX Ends at 19 Thursday, 7 Jan 2010 | 4:53 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks struggled Thursday as the dollar rose and investors remained skittish ahead of Friday's jobs report. GE, Bank of America and Ford were among the day's gainers. Alcoa skidded.

  • Stocks Struggle as Dollar Gains; Sears Rallies Thursday, 7 Jan 2010 | 1:55 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks skidded Thursday as the dollar rose, putting pressure on stocks that outweighed encouraging reports on employment and retail sales.  Bank of America, Sears and Bed, Bath &  Beyond were among the early leaders, while Alcoa stumbled.

  • Stocks Lower as Dollar Rises; Builders Gain Thursday, 7 Jan 2010 | 9:34 AM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks opened lower on Wall Street as a rising dollar pressures commodity prices and outweighed another round of positive news in the job market.

  • Futures Lower Despite Good Jobs News Thursday, 7 Jan 2010 | 8:39 AM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Another round of better-than-expected employment figures did little to assuage investors as stock futures pointed to a negative open for Wall Street.

  • On Gaining More Impotence & Weightloss Drugs Wednesday, 23 Dec 2009 | 12:08 PM ET

    I can’t wait until this drug rises to the level where it gets on Joe Kernen’s radar screen because, boy, is he gonna have a good time (not just with the drug perhaps, but mostly with talking on TV about it.) A little TMI, I know, but that’s Joe.

  • Trading Biotech Breakthroughs Wednesday, 18 Nov 2009 | 5:45 PM ET

    The latest erectile dysfunction drug is showing promise of working even faster than those already on the market. Considering it's $3.5 billion market, what's the trade?

  • Vivus Viagra! Wednesday, 18 Nov 2009 | 12:07 PM ET

    VVUS this morning unveiled positive late-stage test results on the ED pill. The company touts that it takes effect in less than 30 minutes and it's out of your system within six hours or so.

  • Lightning Round OT: Potash, Vivus and More Wednesday, 4 Nov 2009 | 9:25 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • Friday At The Fat Fight Friday, 30 Oct 2009 | 12:46 PM ET

    I end the week as I started it: blogging about Vivus and the three-contestant race to make a new prescription diet pill.

  • Cramer makes the call on viewers' favorite stocks.